07-3012. National Institute on Drug Abuse; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Special Review.

    Date: June 28, 2007.

    Time: 1:30 p.m. to 3:30 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call).

    Contact Person: Kesinee Nimit, MD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1432.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Pathway to Independence Award.

    Date: July 11, 2007.

    Time: 1 p.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call).

    Contact Person: Gerald L. McLaughin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 402-6626. gm145a@nih.gov.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, NIDA-K Conflicts.

    Date: July 17, 2007.

    Time: 5 p.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Doubletree Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814.

    Contact Person: Mark Swieter, PhD, Chief, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Suite 220, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1389. ms80x@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS).

    Start Signature

    Dated: June 13, 2007.

    Jennifer Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 07-3012 Filed 6-19-07; 8:45 am]

    BILLING CODE 4140--01-M

Document Information

Effective Date:
6/28/2007
Published:
06/20/2007
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
07-3012
Dates:
June 28, 2007.
Pages:
34025-34025 (1 pages)
PDF File:
07-3012.pdf